ScanSource cuts fiscal 2026 sales and EBITDA outlook as Q2 net sales rise 2.5%
ScanSource reported second-quarter fiscal 2026 net sales of $766.5 million, up 2.5% year over year, and GAAP diluted EPS of $0.75, up from $0.70, while non-GAAP diluted EPS fell to $0.80 from $0.85. The company replaced its prior fiscal 2026 outlook with lower net sales of $3.0 billion to $3.1 billion and lower adjusted EBITDA of $140 million to $150 million, so shareholders face a weaker full-year forecast despite higher quarterly sales.
Key points
- Q2 net sales were $766.5 million, up 2.5%; adjusted EBITDA was $31.2 million, down 11.6%.
- GAAP diluted EPS was $0.75 versus $0.70; non-GAAP diluted EPS was $0.80 versus $0.85.
- FY26 net sales outlook cut to $3.0 billion to $3.1 billion from $3.1 billion to $3.3 billion.
- FY26 adjusted EBITDA outlook cut to $140 million to $150 million from $150 million to $160 million; free cash flow outlook unchanged at at least $80 million.
The filing
Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.